Photo from wikipedia
T cell checkpoint blockades can produce durable clinical responses, but only some patients and cancer types respond. In this issue of Immunity, Li et al. (2018) show B7S1-B7S1R signaling additionally regulates… Click to show full abstract
T cell checkpoint blockades can produce durable clinical responses, but only some patients and cancer types respond. In this issue of Immunity, Li et al. (2018) show B7S1-B7S1R signaling additionally regulates CD8+ T cell responses by working with the PD1-PDL1 checkpoint to block anti-tumor immunity.
Keywords:
pd1;
better together;
checkpoint blockade;
together b7s1;
checkpoint;
b7s1 checkpoint
Journal Title: Immunity
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Immunity
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!